Fujifilm Diosynth Biotechnologies U.S.A (FDBU) announced on Dec. 18, 2014 that it completed the acquisition of Kalon Biotherapeutics, a biopharmaceutical CMO formed by The Texas A&M University System in 2011. The agreement came to the publics attention in October 2014 when FujifilmOriginal Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.